Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Base de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Curr Microbiol ; 72(1): 19-28, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26364189

RESUMEN

Sub-inhibitory concentrations of antibiotics are always generated as a consequence of antimicrobial therapy and the effects of such residual products in bacterial morphology are well documented, especially the filamentation generated by beta-lactams. The aim of this study was to investigate some morphological and pathological aspects (virulence factors) of Escherichia coli cultivated under half-minimum inhibitory concentration (1.0 µg/mL) of piperacillin-tazobactam (PTZ sub-MIC). PTZ sub-MIC promoted noticeable changes in the bacterial cells which reach the peak of morphological alterations (filamentation) and complexity at 16 h of antimicrobial exposure. Thereafter the filamentous cells and a control one, not treated with PTZ, were comparatively tested for growth curve; biochemical profile; oxidative stress tolerance; biofilm production and cell hydrophobicity; motility and pathogenicity in vivo. PTZ sub-MIC attenuated the E. coli growth rate, but without changes in carbohydrate fermentation or in traditional biochemical tests. Overall, the treatment of E. coli with sub-MIC of PTZ generated filamentous forms which were accompanied by the inhibition of virulence factors such as the oxidative stress response, biofilm formation, cell surface hydrophobicity, and motility. These results are consistent with the reduced pathogenicity observed for the filamentous E. coli in the murine model of intra-abdominal infection. In other words, the treatment of E. coli with sub-MIC of PTZ suggests a decrease in their virulence.


Asunto(s)
Antibacterianos/metabolismo , Escherichia coli/citología , Escherichia coli/efectos de los fármacos , Ácido Penicilánico/análogos & derivados , Animales , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Modelos Animales de Enfermedad , Escherichia coli/patogenicidad , Escherichia coli/fisiología , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/patología , Infecciones Intraabdominales/microbiología , Infecciones Intraabdominales/patología , Locomoción/efectos de los fármacos , Metabolismo/efectos de los fármacos , Ratones , Pruebas de Sensibilidad Microbiana , Ácido Penicilánico/metabolismo , Piperacilina/metabolismo , Combinación Piperacilina y Tazobactam , Virulencia/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA